{
    "clinical_study": {
        "@rank": "107468", 
        "arm_group": [
            {
                "arm_group_label": "Oral Antibiotics", 
                "arm_group_type": "Experimental", 
                "description": "Oral antibiotics for 3 months; recommendation for antibiotics will be made by an infectious disease specialist."
            }, 
            {
                "arm_group_label": "No oral antibiotics", 
                "arm_group_type": "No Intervention", 
                "description": "No oral antibiotics."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary purpose of this study is to compare the re-infection rates in patients\n      undergoing 2-stage revision arthroplasty who receive additional oral antibiotic therapy to\n      those patients who received in-hospital perioperative antibiotic only. Patients will be\n      monitored for re-infection following hospital discharge, defined as deep infection of the\n      joint space/capsule that requires return to the operating room within 24-months of the\n      re-implantation procedure."
        }, 
        "brief_title": "Oral Antibiotics After 2-Stage Revision for Infected Total Hip Arthroplasty and Total Knee Arthroplasty", 
        "condition": "Prosthesis-Related Infections", 
        "condition_browse": {
            "mesh_term": "Prosthesis-Related Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n        Adult patients undergoing 2-stage revision arthroplasty of the knee or hip with the\n        causative organism(s) identified using tissue culture and/or joint fluid analysis that is\n        amenable to oral antibiotic therapy. Patients must be able to tolerate oral antibiotics\n        and agree to participate in the study.\n\n        Exclusion criteria:\n\n        Patients with a fungal prosthetic joint infection, unable to tolerate or refuse to undergo\n        oral antibiotic therapy, unable to follow-up at the specified intervals, allergic to the\n        therapy of preference, or have an organism that is not amenable to oral antibiotic\n        therapy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01760863", 
            "org_study_id": "11040802"
        }, 
        "intervention": {
            "arm_group_label": "Oral Antibiotics", 
            "description": "Oral Antibiotics will be prescribed for 3 months per recommendations of an infectious disease specialist.", 
            "intervention_name": "Oral Antibiotics", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Revision", 
            "Knee", 
            "Hip", 
            "Arthroplasty", 
            "Oral", 
            "Antibiotics", 
            "Infection"
        ], 
        "lastchanged_date": "August 20, 2013", 
        "location": [
            {
                "contact": {
                    "email": "darren.plummer@rushortho.com", 
                    "last_name": "Darren R Plummer, MBA", 
                    "phone": "312-432-2468"
                }, 
                "contact_backup": {
                    "email": "craigdv@yahoo.com", 
                    "last_name": "Craig J Della Valle, MD", 
                    "phone": "312-432-2350"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60607"
                    }, 
                    "name": "Rush University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Craig J Della Valle, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "scott.sporer@rushortho.com", 
                    "last_name": "Scott M Sporer, MD,MS"
                }, 
                "facility": {
                    "address": {
                        "city": "Winfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60190"
                    }, 
                    "name": "Central DuPage Hospital"
                }, 
                "investigator": {
                    "last_name": "Scott M Sporer, MD, MS", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "parvj@aol.com", 
                    "last_name": "Javad Parvizi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Rothman Institute"
                }, 
                "investigator": {
                    "last_name": "Javad Parvizi, MD, FRCS", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Utility of Oral Antibiotic Therapy Following 2-stage Revision Arthroplasty for Infected Prosthetic Hips and Knees", 
        "overall_contact": {
            "email": "craigdv@yahoo.com", 
            "last_name": "Craig J Della Valle, MD", 
            "phone": "3124322350"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Infection Rate", 
            "safety_issue": "No", 
            "time_frame": "24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01760863"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rush University Medical Center", 
            "investigator_full_name": "Craig J Della Valle", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "20213514", 
            "citation": "Zywiel MG, Johnson AJ, Stroh DA, Martin J, Marker DR, Mont MA. Prophylactic oral antibiotics reduce reinfection rates following two-stage revision total knee arthroplasty. Int Orthop. 2011 Jan;35(1):37-42. doi: 10.1007/s00264-010-0992-x. Epub 2010 Mar 7."
        }, 
        "source": "Rush University Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rush University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}